Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder

Clinical trial NCT00105989 · COMPLETED

Trial details

NCT number: NCT00105989
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2005-03-01
Primary completion: 2008-01-01
Enrollment: 514

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.